EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitMetaanalyseOpen Access · CC BY 4.0

The Impact of Red Yeast Rice Extract Use on the Occurrence of Muscle Symptoms and Liver Dysfunction: An Update from the Adverse Event Reporting Systems and Available Meta-Analyses

Giuseppe Danilo Norata iD, Maciej Banach iD

Nutrients · 2024

DOI: 10.3390/nu16030444 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, 2024. Verfasst von Giuseppe Danilo Norata und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacological and Biomolecular Sciences, University of Milan, 20133 Milan, Italy. Hauptthemen laut MEDLINE: Biological Products, Liver Diseases. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Progetti di Rilevante Interesse Nazionale, Ricerca Finalizzata, Ministry of Health, PNRR Missione 4.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Red yeast rice (RYR) has a cholesterol-lowering effect due to the presence of bioactive components (monacolins, mainly monacolin K) that act by inhibiting the activity of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase. The European Food Safety Authority (EFSA) assessed the use of RYR and, while pointing out several uncertainties regarding the available data, raised a warning related to the safety of RYR when used as a food supplement at a dose of monacolin as low as 3 mg/day. In their decision in June 2023, EFSA approved the use of monacolins from RYR at doses less than 3 mg/day. We therefore decided to interrogate the different adverse event reporting systems (FAERS and CAERS) and analyse the characteristics of the cases reported to be associated with RYR supplements, and we reviewed the most recent meta-analyses with a focus on the occurrence of muscle symptoms and liver dysfunction. In terms of all musculoskeletal disorders from September 2013 (when the first case related to RYR consumption was recorded) to 30 September 2023, 363,879 cases were reported in the FAERS, with the number of cases related to RYR consumption being very small and accounting for 0.008% of cases. In the same time frame, 27,032 cases of hepatobiliary disorders were reported, and the cases attributable to RYR ingestion accounted for 0.01% of all cases. A low rate of muscle symptoms and liver dysfunction attributed to RYR ingestion was also observed in the CAERS database, where only 34 cases of adverse muscle events and 10 cases of adverse liver events reported RYR as the suspect product, while 19 cases of both muscle events and 10 cases of adverse liver events reported it as a concomitant product. This profile mirrors that of meta-analyses of randomised clinical trials of RYR, in which RYR use was not associated with either liver dysfunction or muscular adverse symptoms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biological ProductsLiver DiseasesHumansLovastatinDietary SupplementsMusclesPlant Extracts

Stichwörter der Autor:innen

LDL-Clipid loweringliver adverse eventsmonacolin Kmuscle adverse eventsred yeast rice

Substanzen

red yeast riceLovastatinBiological ProductsPlant Extracts

Autor:innen und Institutionen

  • Department of Pharmacological and Biomolecular Sciences, University of Milan, 20133 Milan, Italy.
  • Center for the Study of Atherosclerosis, Bassini Hospital, 20092 Cinisello Balsamo, Italy.
  • Department of Preventive Cardiology and Lipidology, Medical University of Lodz (MUL), 90-419 Lodz, Poland.

ORCID-Profile: Giuseppe Danilo Norata, Maciej Banach

Förderung

  • Progetti di Rilevante Interesse Nazionale
  • Ricerca Finalizzata, Ministry of Health
  • PNRR Missione 4
  • PNRR Missione 6
  • European Commission
  • PNRR Missione 4, [Progetto CN3-National Center for Gene Therapy and Drugs based on RNA Technology]
  • PNRR Missione 4 [Progetto MUSA-Multilayered Urban Sustainability Action]
  • SISTE

Zitieren

APA

Norata, G. D., & Banach, M. (2024). The Impact of Red Yeast Rice Extract Use on the Occurrence of Muscle Symptoms and Liver Dysfunction: An Update from the Adverse Event Reporting Systems and Available Meta-Analyses. Nutrients. https://doi.org/10.3390/nu16030444

Vancouver

Norata GD, Banach M. The Impact of Red Yeast Rice Extract Use on the Occurrence of Muscle Symptoms and Liver Dysfunction: An Update from the Adverse Event Reporting Systems and Available Meta-Analyses. Nutrients. 2024. doi:10.3390/nu16030444

BibTeX
@article{Norata2024,
  author = {Norata, Giuseppe Danilo and Banach, Maciej},
  title = {The Impact of Red Yeast Rice Extract Use on the Occurrence of Muscle Symptoms and Liver Dysfunction: An Update from the Adverse Event Reporting Systems and Available Meta-Analyses},
  journal = {Nutrients},
  year = {2024},
  doi = {10.3390/nu16030444}
}
Kostenlos starten →